← Open Payments lookup

ANTONY WOEHLE: Open Payments

NPI 1275936791 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,132 in 49 payments from 11 companies in 2025. Trend: 2023 $2,143 · 2024 $1,594 · 2025 $1,132

Food & beverage: $1,132
CompanyPaymentsAmount
ABBVIE INC.10$270
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$248
Otsuka America Pharmaceutical, Inc.9$180
Vanda Pharmaceuticals Inc.6$150
Teva Pharmaceuticals USA, Inc.4$89
Neurocrine BioSciences, Inc.3$87
Noven Therapeutics, LLC2$39
Axsome Therapeutics, Inc.1$24
Collegium Pharmaceutical, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: VRAYLAR, CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA, FANAPT, HETLIOZ, Xelstrym.

Industry payments across FL — which companies pay providers there.